Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 3179-2 (MIR3179-2) is a human microRNA gene located in an intergenic region between the NOMO and PKD1P1 genes on chromosome 16, identified as possessing enhancer activity based on H3K27ac enrichment[1]. Experimental evidence suggests that miR-3179 (closely related to MIR3179-2) can upregulate neighboring genes such as ABCC6 and PKD1P1 in human cells, indicating enhancer-like functionality[1]. Like other microRNAs, MIR3179-2 is produced via canonical biogenesis involving Drosha and Dicer processing, and its mature form participates in post-transcriptional gene silencing through the RNA-induced silencing complex (RISC), typically modulating gene expression by targeting complementary mRNA sequences[2]. Specific biological roles, disease associations, or interactions with small-molecule drugs for MIR3179-2 are currently undefined in primary literature, reflecting its status as a noncoding regulatory RNA rather than a classical therapeutic target[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 3179-2 (MIR3179-2).